Nawal El‐Koussi

581 total citations
29 papers, 457 citations indexed

About

Nawal El‐Koussi is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Nawal El‐Koussi has authored 29 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Nawal El‐Koussi's work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Click Chemistry and Applications (9 papers). Nawal El‐Koussi is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Click Chemistry and Applications (9 papers). Nawal El‐Koussi collaborates with scholars based in Egypt, Saudi Arabia and Japan. Nawal El‐Koussi's co-authors include Bahaa G. M. Youssif, Salah A. Abdel‐Aziz, Hesham A. M. Gomaa, Hamdy M. Abdel‐Rahman, Nadia M. Mahfouz, Mohammed K. Abdel‐Hamid, A. A. ABDEL‐HAFEZ, Claudiu T. Supuran, Alessio Innocenti and Ehab S. Taher and has published in prestigious journals such as Chemical Communications, RSC Advances and Tetrahedron Letters.

In The Last Decade

Nawal El‐Koussi

29 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nawal El‐Koussi Egypt 11 375 164 41 32 28 29 457
Samia G. Abdel‐Moty Egypt 11 333 0.9× 108 0.7× 79 1.9× 29 0.9× 33 1.2× 22 400
Francesco Piscitelli Italy 9 397 1.1× 94 0.6× 34 0.8× 20 0.6× 30 1.1× 12 505
Elisa Bonandi Italy 8 542 1.4× 278 1.7× 31 0.8× 49 1.5× 22 0.8× 11 682
Adina Ryckebusch France 9 277 0.7× 139 0.8× 27 0.7× 29 0.9× 48 1.7× 11 384
Jacek Finster Poland 9 385 1.0× 151 0.9× 26 0.6× 51 1.6× 24 0.9× 14 487
Joane Litvak United States 9 288 0.8× 265 1.6× 41 1.0× 16 0.5× 22 0.8× 11 508
Philipp Lehr Austria 9 191 0.5× 223 1.4× 60 1.5× 24 0.8× 16 0.6× 16 390
Harry J. Wadsworth United Kingdom 8 295 0.8× 190 1.2× 32 0.8× 14 0.4× 19 0.7× 20 446
John D. Trzupek United States 13 449 1.2× 447 2.7× 76 1.9× 35 1.1× 18 0.6× 16 737
Garima Verma India 4 310 0.8× 125 0.8× 36 0.9× 22 0.7× 37 1.3× 7 399

Countries citing papers authored by Nawal El‐Koussi

Since Specialization
Citations

This map shows the geographic impact of Nawal El‐Koussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nawal El‐Koussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nawal El‐Koussi more than expected).

Fields of papers citing papers by Nawal El‐Koussi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nawal El‐Koussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nawal El‐Koussi. The network helps show where Nawal El‐Koussi may publish in the future.

Co-authorship network of co-authors of Nawal El‐Koussi

This figure shows the co-authorship network connecting the top 25 collaborators of Nawal El‐Koussi. A scholar is included among the top collaborators of Nawal El‐Koussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nawal El‐Koussi. Nawal El‐Koussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Koussi, Nawal, et al.. (2025). Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article. RSC Advances. 15(2). 966–1010. 8 indexed citations
2.
3.
Al-Wahaibi, Lamya H., Taha F. S. Ali, Bahaa G. M. Youssif, et al.. (2024). Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors. ACS Omega. 9(32). 34358–34369. 19 indexed citations
4.
Al-Wahaibi, Lamya H., Taha F. S. Ali, Bahaa G. M. Youssif, et al.. (2024). Design and synthesis of new dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition. Frontiers in Chemistry. 12. 1387923–1387923. 8 indexed citations
5.
Ali, Taha F. S., et al.. (2023). Recent progress in biological activities of dihydropyrimidine derivatives: An updated mini-review. 0(0). 114–123. 8 indexed citations
6.
Mohamed, Mamdouh F. A., Hesham A. M. Gomaa, Salah A. Abdel‐Aziz, et al.. (2021). Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Bioorganic Chemistry. 112. 104920–104920. 61 indexed citations
7.
Abdel‐Aziz, Salah A., Ehab S. Taher, Ping Lan, et al.. (2021). Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile. Bioorganic Chemistry. 111. 104890–104890. 49 indexed citations
8.
9.
Abdel‐Aziz, Salah A., et al.. (2011). SYNTHESIS OF SUBSTITUTED DIHYDROPYRIMIDINES AS HYPOTENSIVE AGENTS. Bulletin of Pharmaceutical Sciences Assiut. 34(2). 159–179. 2 indexed citations
10.
Abdel‐Rahman, Hamdy M., et al.. (2009). Fluorinated 1,2,4‐Triazolo[1,5‐a]pyrimidine‐6‐carboxylic Acid Derivatives as Antimycobacterial Agents. Archiv der Pharmazie. 342(2). 94–99. 33 indexed citations
11.
Emara, Kamla M., et al.. (2009). ANALYSIS OF PARACETAMOL AND ASCORBIC ACID IN PHARMACEUTICAL BINARY MIXTURE. Bulletin of Pharmaceutical Sciences Assiut. 32(2). 339–347. 1 indexed citations
12.
Abdel‐Hamid, Mohammed K., A. A. ABDEL‐HAFEZ, Nawal El‐Koussi, et al.. (2007). Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity. Bioorganic & Medicinal Chemistry. 15(22). 6975–6984. 70 indexed citations
13.
El‐Koussi, Nawal, et al.. (2006). Synthesis of 5‐Phenyl‐1‐(3‐pyridyl)‐1H‐1,2,4‐triazole‐3‐carboxylic Acid Derivatives of Potential Anti‐inflammatory Activity. Archiv der Pharmazie. 339(1). 32–40. 38 indexed citations
14.
El‐Koussi, Nawal, et al.. (2004). SYNTHESIS AND ANTIBACTERIAL SCREENING OF SOME 2,5,7TRIARYL-1,2,4-TRIAZOLO[1,5-a]PYRIMIDINES. Bulletin of Pharmaceutical Sciences Assiut. 27(1). 144–154. 2 indexed citations
15.
Abdel‐Rahman, Hamdy M., et al.. (2004). A Novel Dipeptide‐based HIV Protease Inhibitor Containing Allophenylnorstatine. Archiv der Pharmazie. 337(11). 587–598. 2 indexed citations
16.
El‐Koussi, Nawal, et al.. (2003). Brain Delivery of HIV Protease Inhibitors. Archiv der Pharmazie. 336(1). 47–52. 17 indexed citations
17.
Nagaoka, Yasuo, Nawal El‐Koussi, Shinichi Uesato, & Kiyoshi Tomioka. (2002). Conjugate reduction-initiated tandem cyclization of a chiral α,β,χ,ψ–unsaturated bisphosphine oxide. Tetrahedron Letters. 43(24). 4355–4359. 6 indexed citations
18.
Nagaoka, Yasuo, Hideki Inoue, Nawal El‐Koussi, & Kiyoshi Tomioka. (2002). Synthesis and application of chiral bisphosphines through lithiation–conjugate addition tandem cyclization of chiral α,β,ψ,ω-unsaturated bisphosphine oxide. Chemical Communications. 122–123. 10 indexed citations
19.
Abdel‐Rahman, Hamdy M., et al.. (2002). HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives. Current Medicinal Chemistry. 9(21). 1905–1922. 32 indexed citations
20.
El‐Koussi, Nawal, et al.. (1998). Synthesis and Antimicrobial Activity of Pyridines Bearing Thiazoline and Moieties.. Chemical and Pharmaceutical Bulletin. 46(5). 863–866. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samia G. Abdel‐Moty Breakdown of academic impact, for papers by Francesco Piscitelli Breakdown of academic impact, for papers by Elisa Bonandi Breakdown of academic impact, for papers by Adina Ryckebusch Breakdown of academic impact, for papers by Jacek Finster Breakdown of academic impact, for papers by Joane Litvak Breakdown of academic impact, for papers by Philipp Lehr Breakdown of academic impact, for papers by Harry J. Wadsworth Breakdown of academic impact, for papers by John D. Trzupek Breakdown of academic impact, for papers by Garima Verma
Rankless by CCL
2026